⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited KingdomNasdaqGS

KNSA

Kiniksa Pharmaceuticals International, plc

Healthcare · Drug Manufacturers - Specialty & Generic

76.73USD

-4.0600 (-5.03%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on KNSA.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End03/2026 Q1
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 76.73
P/E80.8
Dvd Ind Yld0.0%
P/B9.75
P/S7.8
Curr EV/T12M EBITDA58.1
Mkt Cap (USD)5.9B
Curr EV (USD)5.5B
2)

Per Share Data

EPS T12M0.91
DPS0.00
Bk Val Per Sh8.39
Rev/Sh9.15
Cash/Sh6.74
Curr Shares Out46.3M
FCF/Sh1.99
3)

Cash Flow Analysis

P/CF35.6
Curr P/FCF35.9
CF/NI2.3
Dvd P/O0.0%
Cash Gen/Cash Reqd101.8
Csh Dvd Cov—
CFO/Sales22.0%
Eff Interest Rate—
4)

Growth Potential

Dil EPS 1Y Gr225.0%
Cap 1Y Gr29.5%
BPS 1Y Gr17.1%
R&D To Sales13.9%
Retention Rate100.0%
Rev 1Y Gr60.1%
FCF 1Y Gr436.8%
Assets 1Y Gr31.5%
5)

Profitability

EBITDA0.1B
EBIT0.1B
Operating Margin12.4%
Pretax Margin14.1%
Net Margin9.7%
ROA10.3%
ROE13.7%
ROC10.5%
Asset Turnover1.06
6)

Structure

Current Ratio3.79
Quick Ratio3.21
Debt/Assets1.1%
Debt/Com Eq1.5%
Net Debt/EBITDA-1.92
Tot Debt/Capital1.4%
Gross Margin89.3%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.